Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (141-150 of 243) with videos related to

Pageof 25
Sort By:
Oncology|September 7, 2013
FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survivalChristina Schaub, Susanne Greschus, Mirko Seifert, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.
BMC Cancer|January 26, 2024
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastomaSophie Heuer, Ina Burghaus, Maria Gose, et al.
Journal of Clinical Medicine|September 10, 2021
The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of SurvivalMatthias Schneider, Niklas Schäfer, Christian Bode, et al.
Cancer Medicine|April 2, 2026
Regrowth Patterns in Glioblastoma-Survival and PredictorsJonas A Feldheim, Jana Grieger, Teresa Schmidt, et al.
Cancers|June 23, 2019
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for TemozolomideAnna-Laura Potthoff, Dieter Henrik Heiland, Bernd O Evert, et al.
Neuro-Oncology|December 7, 2013
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)Markus Hutterer, Martha Nowosielski, Johannes Haybaeck, et al.
Advances in Radiation Oncology|March 17, 2025
<i>Boswellia serrata</i> for the Management of Radiation-Induced Cerebral Edema and Necrosis: A Systematic Meta-Narrative Review of Clinical EvidenceCas Stefaan Dejonckheere, Davide Scafa, Lukas Käsmann, et al.
Journal of Cancer Research and Clinical Oncology|September 28, 2024
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infectionThomas Zeyen, Lea L Friker, Daniel Paech, et al.
Annals of Neurology|August 10, 2010
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Barbara H Rath, Matthias Simon, et al.
Pageof 25

Showing results (141-150 of 243) with videos related to

Sort By:
Pageof 25
Oncology|September 7, 2013
FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survivalChristina Schaub, Susanne Greschus, Mirko Seifert, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.
BMC Cancer|January 26, 2024
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastomaSophie Heuer, Ina Burghaus, Maria Gose, et al.
Journal of Clinical Medicine|September 10, 2021
The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of SurvivalMatthias Schneider, Niklas Schäfer, Christian Bode, et al.
Cancer Medicine|April 2, 2026
Regrowth Patterns in Glioblastoma-Survival and PredictorsJonas A Feldheim, Jana Grieger, Teresa Schmidt, et al.
Cancers|June 23, 2019
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for TemozolomideAnna-Laura Potthoff, Dieter Henrik Heiland, Bernd O Evert, et al.
Neuro-Oncology|December 7, 2013
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)Markus Hutterer, Martha Nowosielski, Johannes Haybaeck, et al.
Advances in Radiation Oncology|March 17, 2025
<i>Boswellia serrata</i> for the Management of Radiation-Induced Cerebral Edema and Necrosis: A Systematic Meta-Narrative Review of Clinical EvidenceCas Stefaan Dejonckheere, Davide Scafa, Lukas Käsmann, et al.
Journal of Cancer Research and Clinical Oncology|September 28, 2024
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infectionThomas Zeyen, Lea L Friker, Daniel Paech, et al.
Annals of Neurology|August 10, 2010
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Barbara H Rath, Matthias Simon, et al.
Pageof 25